U.S. Markets closed

Rosetta Genomics Ltd. (ROSG)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.36-0.07 (-4.90%)
At close: 4:00PM EDT
People also watch
RXIICLSNPSTIOPXACYCC
  • J
    Jason
    Jason

    I will clear this up for you. $ROSG is an Israeli company. They file earnings TWICE yearly, as per their foreign-based reporting requirements. Once at end of March, once at end of September. Earnings will be out next week. I expect very solid Reveal sales. In next week's semi-annual report I expect Kenny will update us on patent developments. There have been a number of them. fully diluted share count is under 7M shares. Fully diluted MC is less than $10M. They will do more than $10M this year in revenues. Reveal revenues expected to increase from $800k last year to $4,000,000+ this year. That is crazy growth. Reveal could challenge $VCYT indeterminate thyroid nodule test Afirma, which does $16,000,000 in revenues per quarter, or $64,000,000 a year. ROSG has nearly no debt, MC of less than $10M fully diluted, growing revenues north of $10M annually, just increased its cash position, and could be cash flow positive easily by next year, with growing Reveal sales. Plus has a treasure trove of patents for using microRNA sequencing as a diagnostic for all sorts of indications (thyroid, gastric, ovarian, even Alzheimers patent pending). Finally, they appear to have reached agreement with Clinical Pathology Laboratories https://www.cpllabs.com/ to use Reveal indeterminate thyroid test exclusively in their network of hundreds of physicians.

  • J
    Jake
    Jake
    Pump and dump with NO product to sell! I know what I am talking about here! Get out while you can!
  • J
    Jason
    Jason
    "$ROSG has capturing 50% of the current intellectual property (IP) surrounding commercial use of microRNA’s ... "the other major player in this field is ISIS and Alnylam Pharmaceuticals, having captured most of the remaining IP space."
  • J
    Jason
    Jason
    I have shared a lot of my thoughts on $ROSG on the $ROSG Stocktwits page. I am Turquoise. Following along if your interested. I would link to it here but I think links aren't allowed.
  • L
    Littleguy
    Littleguy
    We have volume and share price climbing. Still not to the $1.70 secondary price, but up is good.
  • J
    Jake
    Jake
    Just FYI but CFO was the CFO of Toys R US! Just look what happened to them! Busted Pedro!
  • J
    Jason
    Jason

    $ROSG $ALNY $IONS an absolute must read https://seekingalpha.com/article/197638-rosetta-genomics-giving-isis-and-alnylam-a-run-for-their-mirnas

    Rosetta Genomics: Giving Isis and Alnylam a Run for Their miRNAs?
    In late 2007, Isis Pharmacueticals (ISIS) and Alnylam Pharmaceuticals (NASDAQ:ALNY) created a joint venture, operated as an independent company, called Regulus
    seekingalpha.com
  • G
    Guerilla Trades
    Guerilla Trades
    Strong buying here. Long!
  • m
    michael
    michael
    so. no .bews seeking alpha lied..but 3m volume could spell then end
  • m
    michael
    michael
    ha what a sham. shabby at its best
  • m
    michael
    michael
    this must be the end. 550 shares. now we break a dollar
  • G
    Guerilla Trades
    Guerilla Trades
    long again here.
  • h
    hqpwwkwr
    hqpwwkwr

    The dork has improved my trading times 10. See for yourself at https://greatprofit12.blogspot.com/

    Penny Stocks
    greatprofit12.blogspot.com
  • m
    michael
    michael
    they only raised 4million dollars. will dilute again.or done
  • J
    Justin
    Justin
    woah volume
  • L
    Littleguy
    Littleguy
    $4 million market cap. Perhaps they should buy a McD's franchise with the $4 million. At least there would be revenue
  • L
    Littleguy
    Littleguy
    Well, look at that! Even those folks who bought the last secondary at $1.70 are down 20%. Of course they sold right away and just hung onto the options. All upside, no downside.
  • L
    Littleguy
    Littleguy
    Anyone understand the need to authorize more shares and increase the shares in the employee incentive plan? Prospectus doesn't say a thing.
  • m
    michael
    michael
    what a joke...patents?? cant afford to pay employees. think they can afford to defend patents....why make these comical announcement